[{"address1": "11682 El Camino Real", "address2": "Suite 120", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 771 9307", "website": "https://ars-pharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.", "fullTimeEmployees": 155, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard  Lowenthal M.B.A., M.S., MSMSEL", "age": 58, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 2746096, "exercisedValue": 0, "unexercisedValue": 2051778}, {"maxAge": 1, "name": "Dr. Sarina  Tanimoto M.B.A., M.D.", "age": 55, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 2470993, "exercisedValue": 0, "unexercisedValue": 718122}, {"maxAge": 1, "name": "Mr. Alexander A. Fitzpatrick Esq.", "age": 57, "title": "Chief Legal Officer & Secretary", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 677145, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert  Bell Ph.D.", "title": "Co-Founder & Chief Science Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen D. Scott CPA", "title": "Chief Financial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian T. Dorsey M.S.", "age": 55, "title": "Chief Operations Officer", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Relovsky", "title": "Senior Vice President of Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harris  Kaplan M.B.A.", "age": 72, "title": "Executive Vice President of Commercial Strategy", "yearBorn": 1952, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Karas", "age": 51, "title": "Chief Commercial Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 618614, "exercisedValue": 0, "unexercisedValue": 4320554}, {"maxAge": 1, "name": "Mr. Justin  Chakma", "age": 34, "title": "Chief Business Officer & Secretary", "yearBorn": 1990, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 12.63, "open": 12.63, "dayLow": 12.21, "dayHigh": 12.78, "regularMarketPreviousClose": 12.63, "regularMarketOpen": 12.63, "regularMarketDayLow": 12.24, "regularMarketDayHigh": 12.78, "payoutRatio": 0.0, "beta": 1.411, "trailingPE": 156.125, "forwardPE": -16.43421, "volume": 1173934, "regularMarketVolume": 1173934, "averageVolume": 1554967, "averageVolume10days": 2748460, "averageDailyVolume10Day": 2748460, "bid": 12.45, "ask": 12.55, "bidSize": 1, "askSize": 1, "marketCap": 1225516288, "fiftyTwoWeekLow": 7.55, "fiftyTwoWeekHigh": 18.51, "priceToSalesTrailing12Months": 13.746832, "fiftyDayAverage": 12.154, "twoHundredDayAverage": 12.377375, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 980919360, "profitMargins": 0.08971, "floatShares": 47452700, "sharesOutstanding": 98119800, "sharesShort": 19429266, "sharesShortPriorMonth": 16483868, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1984, "heldPercentInsiders": 0.22973, "heldPercentInstitutions": 0.75154996, "shortRatio": 15.06, "shortPercentOfFloat": 0.3704, "impliedSharesOutstanding": 98119800, "bookValue": 2.622, "priceToBook": 4.7635393, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": 7998000, "trailingEps": 0.08, "forwardEps": -0.76, "enterpriseToRevenue": 11.003, "enterpriseToEbitda": -326.538, "52WeekChange": 0.31890178, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 12.49, "targetHighPrice": 40.0, "targetLowPrice": 19.0, "targetMeanPrice": 29.5, "targetMedianPrice": 30.0, "recommendationMean": 1.16667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 314022016, "totalCashPerShare": 3.2, "ebitda": -3004000, "totalDebt": 69425000, "quickRatio": 13.788, "currentRatio": 14.262, "totalRevenue": 89149000, "debtToEquity": 27.035, "revenuePerShare": 0.92, "returnOnAssets": -0.0066000004, "returnOnEquity": 0.03281, "grossProfits": 68592000, "freeCashflow": 8960125, "operatingCashflow": 13548000, "grossMargins": 0.76941, "ebitdaMargins": -0.0337, "operatingMargins": 0.54512, "financialCurrency": "USD", "symbol": "SPRY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketTime": 1743195804, "regularMarketTime": 1743192001, "exchange": "NGM", "messageBoardId": "finmb_585213447", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "ARS Pharmaceuticals, Inc.", "longName": "ARS Pharmaceuticals, Inc.", "corporateActions": [], "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607092200000, "postMarketChangePercent": 0.0800659, "postMarketPrice": 12.5, "postMarketChange": 0.0100002, "regularMarketChange": -0.14000034, "regularMarketDayRange": "12.24 - 12.78", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1554967, "fiftyTwoWeekLowChange": 4.9399996, "fiftyTwoWeekLowChangePercent": 0.65430456, "fiftyTwoWeekRange": "7.55 - 18.51", "fiftyTwoWeekHighChange": -6.0200005, "fiftyTwoWeekHighChangePercent": -0.32522961, "fiftyTwoWeekChangePercent": 31.890179, "earningsTimestamp": 1736767801, "earningsTimestampStart": 1746615540, "earningsTimestampEnd": 1747051200, "earningsCallTimestampStart": 1742473800, "earningsCallTimestampEnd": 1742473800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 0.08, "epsForward": -0.76, "epsCurrentYear": -1.4325, "priceEpsCurrentYear": -8.719023, "fiftyDayAverageChange": 0.3359995, "fiftyDayAverageChangePercent": 0.027645176, "twoHundredDayAverageChange": 0.11262512, "twoHundredDayAverageChangePercent": 0.009099274, "regularMarketChangePercent": -1.1084746, "regularMarketPrice": 12.49, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Silverback Therapeutics, Inc.", "nameChangeDate": "2025-03-28", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "displayName": "ARS Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]